Search Results - Rucha Sane
- Showing 1 - 7 results of 7
-
1
-
2
Drug–Drug Interaction Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Ipatasertib in Combination with Darolutamide in Patients with Advanced Prostate Cancer by Dhruvitkumar S. Sutaria, Grozdana Rasuo, Adam Harris, Ryan Johnson, Dale Miles, Jorge Daniel Gallo, Rucha Sane
Published in Pharmaceutics (2022-10-01)Get full text
Article -
3
Understanding CYP3A4 and P‐gp mediated drug–drug interactions through PBPK modeling – Case example of pralsetinib by Christine Bowman, Michael Dolton, Fang Ma, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Nastya Kassir, Yuan Chen
Published in CPT: Pharmacometrics & Systems Pharmacology (2024-04-01)Get full text
Article -
4
Predicting overall survival from tumor dynamics metrics using parametric statistical and machine learning models: application to patients with RET-altered solid tumors by Erick Velasquez, Nastya Kassir, Sravanthi Cheeti, Denison Kuruvilla, Rucha Sane, Steve Dang, Dale Miles, James Lu
Published in Frontiers in Artificial Intelligence (2024-06-01)Get full text
Article -
5
Pharmacokinetics, safety and tolerability of ipatasertib in combination with palbociclib and fulvestrant in patients with advanced breast cancer in a phase Ib study by Kit Wun Kathy Cheung, Ksenia Arzumanova, Victor Poon, Adam Harris, Ryan Johnson, Frauke Schimmoller, Rucha Sane
Published in Frontiers in Pharmacology (2025-09-01)Get full text
Article -
6
Exploring the Impact of Hepatic Impairment on Pralsetinib Pharmacokinetics by Kit Wun Kathy Cheung, Yang Tang, Doreen Anders, Teresa Barata, Astrid Scalori, Priya Agarwal, Rucha Sane, Sravanthi Cheeti
Published in Pharmaceutics (2024-04-01)Get full text
Article -
7
Impact of P‐gp inhibition on systemic exposure of pralsetinib and dosing considerations by Julia Suchomel, Priya Agarwal, Doreen Anders, Kevin Hughes, Yang Tang, Rucha Sane, Astrid Scalori, Sunil Sharma, Sravanthi Cheeti
Published in Clinical and Translational Science (2024-06-01)Get full text
Article
